Industry News
UQ-led teams to develop advanced cattle vaccines
Two University of Queensland scientists are leading teams to develop cutting-edge vaccines aimed at fighting cattle tick infestation and common bovine diseases. [ + ]
Top performing biotechs delivered over 100% returns in FY12
The three top performing life science stocks over the last four quarters delivered more than 100% returns over that time. [ + ]
Sirtex study to pave way for wider use of SIR-Spheres
A large-scale trial could pave the way for wider adoption of Sirtex Medical's (ASX:SRX) SIR-Spheres in first-line oncology therapy. [ + ]
Commercialisation Australia to provide more support for manufacturing
New funding guidelines, foreshadowed in December, deliver more generous arrangements for early stage commercialisation (ESC) grant recipients needing to establish manufacturing facilities in Australia to fully commercialise their invention. [ + ]
No reason to feel sheepish about paternity
Figuring out which lambs are the offspring of which sheep can be guesswork for sheep producers. A new, low-cost DNA test to verify sheep parentage could soon help breeders worldwide to record accurate pedigrees and maximise the genetic potential of their flock. [ + ]
CSIRO to supply essential antibodies in the search for new rotavirus vaccines
CSIRO has been contracted by PATH (Program for Appropriate Technology in Health) to produce antibodies on a large scale that will aid the development of new, safe, affordable and effective vaccines against rotavirus, a major cause of severe and fatal diarrhoea in young children worldwide. [ + ]
Education reform needs stronger science focus, says La Trobe Chancellor
With higher education undergoing profound change - reflecting challenges in environmental degradation, food security, emerging diseases and more - La Trobe University Chancellor Adrienne E Clarke AC has called for urgent action to boost Australia’s scientific understanding and awareness. [ + ]
Bioshares summit to discuss bypassing big pharma
A central theme of this week's Bioshares Biotech Summit in New Zealand is the trend of foregoing outlicensing to big pharma in order to bring products to market alone or with a smaller partner. [ + ]
GI Dynamics extends reach of diabetes treatment
GI Dynamics (ASX:GID) has expanded the reach of its EndoBarrier diabetes treatment to France and to more clinics in its existing markets. [ + ]
Biotechs undo gains from last quarter
Many Australian biotech stocks have seen a reversal of fortune in the most recent quarter, with market volatility and some disappointing results hampering share prices. [ + ]
Student volunteer program and excellence awards closing soon
Two of AusBiotech’s most important student programs to assist bio-students’ linkages with industry are closing soon for 2012. [ + ]
Detecting new designer drugs
A new method of drug testing developed by researchers at RTI International makes it possible to detect a wider range of synthetically produced ‘designer’ drugs. [ + ]
Water is a surfactant in water
Textbooks and websites on the origin of the surface tension of water need to be rewritten, according to Maoyuan Liu, James K Beattie and Angus Anthony Gray-Weale. These textbooks describe a pristine, uncharged air/water interface. None recognise that the interface is in fact highly charged by the presence of adsorbed hydroxide ions, with hydronium ions providing charge balance in the double layer. [ + ]
Vaccine for obesity
A recent study assesses the effectiveness of two somatostatin vaccinations, JH17 and JH18, in reducing weight gain and increasing weight loss in mice. [ + ]
Feature: Silent epidemic
Aboriginal children in the Northern Territory suffer from one of the world’s highest rates of otitis media – i.e. bacterial infections of the middle ear – which can lead to a lifetime of health problems. [ + ]